The piece traces the science, the sniffers (mostly beagles, at a facility they call Sniffspace), and the recent study published in the Journal of Clinical Oncology. As Dognosis pursues commercial approval, it's collaborating with government medical institutions on further research, with a commercial launch planned for next year, making it only the third company of its kind in the world.